Michael Hackman
Psychiatry · Huntington, WVNPI 1013150945
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,800 of the $18,063 with a category attached, or 76.4%. AbbVie accounts for 93.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $9,390 and has fallen 93.0% since, to $659 in 2025. Among psychiatry clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $100.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- Otsuka America Pharmaceutical, Inc.$353
- Axsome Therapeutics, Inc.$293
- Takeda Pharmaceuticals U.S.A., Inc.$167
- Sunovion Pharmaceuticals Inc.$102
- Lundbeck LLC$92
- plus $247 from 8 others
What the payments were for
- Speaking & faculty fees$13,80076%
- Travel & lodging$1,4888%
- Food & beverage$2,77515%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 110 | $16,808 |
| Otsuka America Pharmaceutical, Inc. | 20 | $353 |
| Axsome Therapeutics, Inc. | 14 | $293 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $167 |
| Sunovion Pharmaceuticals Inc. | 6 | $102 |
| Lundbeck LLC | 5 | $92 |
| Alkermes, Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $44 |
| Johnson & Johnson | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$15,174
How this compares
$18,063 in reported general payments places this provider in the 90th percentile of 177 psychiatry providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 15 | $33,519 |
| CaplytaLumateperone Tosylate | 20 | $32,698 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 60 | $24,485 |
| VraylarCariprazine Hcl | 17 | $23,787 |
| Chlorpromazine Hcl | 27 | $17,417 |
| Aripiprazole | 104 | $12,153 |
| Divalproex Sodium | 112 | $9,602 |
| Oxcarbazepine | 84 | $6,215 |
| BelsomraSuvorexant | 14 | $5,945 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 35 | $4,790 |
| Risperidone | 199 | $4,213 |
| Buspirone Hcl | 148 | $3,698 |
| Trazodone Hcl | 250 | $3,024 |
| Quetiapine Fumarate | 114 | $2,559 |
| Sertraline Hcl | 240 | $2,475 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $353 | $33,51915 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $44 | $32,69820 claims |
| AbbVieVraylar | $16,808 | $23,78717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 177 psychiatry providers in West Virginia.
Other psychiatry in Huntington
- Nika RazavipourHuntington$4K
- Kambiz SoleymaniHuntington$1K
- Carol KleinHuntington$1K
- Thomas WilliamsHuntington$641
- Melissa MoodyCharleston$1.2M
- April BaisdenScott Depot$775K
- Ryan WakimWheeling$772K
- Daniel ThistlethwaiteSouth Charleston$468K
- Walter ByrdMorgantown$299K
- Fahd MousaCharleston$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.